Otorhinolaryngologic Diseases
Welcome,         Profile    Billing    Logout  
 95 Companies   180 Products   180 Products   97 Mechanisms of Action   2 Trials   2111 News 


«12345678910111213...4243»
  • ||||||||||  Trial primary completion date, Surgery:  Randomized Control Trials of Surgery for Pediatric OSA (clinicaltrials.gov) -  Jan 3, 2018   
    P=N/A,  N=160, Recruiting, 
    Trial primary completion date: Oct 2016 --> Dec 2018
  • ||||||||||  olopatadine / Generic mfg.
    Trial completion:  Safety Study of Olopatadine Nasal Spray (clinicaltrials.gov) -  Dec 19, 2017   
    P3,  N=890, Completed, 
    Recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Zinc to Treat Tinnitus in the Elderly (clinicaltrials.gov) -  Dec 19, 2017   
    P2,  N=116, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | N=200 --> 116 | Trial primary completion date: Dec 2009 --> Dec 2011
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Endoscopic Overlay Tympanoplasty for TM Perforation (clinicaltrials.gov) -  Dec 19, 2017   
    P=N/A,  N=64, Completed, 
    Recruiting --> Completed | N=200 --> 116 | Trial primary completion date: Dec 2009 --> Dec 2011 Recruiting --> Completed | N=21 --> 64 | Trial primary completion date: Dec 2016 --> Oct 2017 | Recruiting --> Completed | N=21 --> 64 | Trial primary completion date: Dec 2016 --> Oct 2017 | Recruiting --> Completed | N=21 --> 64 | Trial primary completion date: Dec 2016 --> Oct 2017
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date, Surgery:  Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma (clinicaltrials.gov) -  Dec 15, 2017   
    P2,  N=1, Terminated, 
    Recruiting --> Completed | N=21 --> 64 | Trial primary completion date: Dec 2016 --> Oct 2017 | Recruiting --> Completed | N=21 --> 64 | Trial primary completion date: Dec 2016 --> Oct 2017 | Recruiting --> Completed | N=21 --> 64 | Trial primary completion date: Dec 2016 --> Oct 2017 N=150 --> 1 | Recruiting --> Terminated | Trial primary completion date: Sep 2019 --> Dec 2017; Another trial in the department directly competes for the the same patient population
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Novel Imaging of the Eustachian Tube; Patient Study (clinicaltrials.gov) -  Dec 2, 2017   
    P=N/A,  N=24, Completed, 
    Recruiting --> Suspended Recruiting --> Completed | N=65 --> 24 | Trial primary completion date: Dec 2016 --> Oct 2017
  • ||||||||||  Trial completion, Trial primary completion date:  National Trends in Otitis Media in Children Under 5 Years of Age (clinicaltrials.gov) -  Nov 24, 2017   
    P=N/A,  N=1, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Oct 2017 --> Apr 2015 Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Jun 2017
  • ||||||||||  sodium oxybate / Generic mfg.
    Trial completion, Phase classification, Enrollment change:  Voice Tremor in Spasmodic Dysphonia: Central Mechanisms and Treatment Response (clinicaltrials.gov) -  Nov 22, 2017   
    P2,  N=53, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Jun 2017 Recruiting --> Completed | Phase classification: PN/A --> P2 | N=95 --> 53
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Efficacy of Vitamin D and Calcium Supplementation on the Prevention of Recurrences in BPPV (clinicaltrials.gov) -  Nov 17, 2017   
    P4,  N=1050, Completed, 
    Recruiting --> Completed | Phase classification: PN/A --> P2 | N=95 --> 53 Recruiting --> Completed | N=2018 --> 1050 | Trial primary completion date: Dec 2016 --> May 2017
  • ||||||||||  prednisolone / Generic mfg., fluticasone / Generic mfg.
    Trial termination:  Management of Recurrent Croup (clinicaltrials.gov) -  Nov 13, 2017   
    P3,  N=10, Terminated, 
    Recruiting --> Completed | N=2018 --> 1050 | Trial primary completion date: Dec 2016 --> May 2017 Completed --> Terminated
  • ||||||||||  Synflorix (10-valent pneumococcal conjugate vaccine) / GSK
    Enrollment closed, Trial primary completion date, Pneumococcal vaccines:  PREVIX_COMBO: Pneumococcal Vaccines Early and in Combination (clinicaltrials.gov) -  Nov 13, 2017   
    P4,  N=425, Active, not recruiting, 
    Completed --> Terminated Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2016 --> Sep 2017
  • ||||||||||  Piqray (alpelisib) / Novartis, Erbitux (cetuximab) / Eli Lilly
    Enrollment change, Trial withdrawal:  Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma (clinicaltrials.gov) -  Nov 13, 2017   
    P1/2,  N=0, Withdrawn, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2016 --> Sep 2017 N=62 --> 0 | Not yet recruiting --> Withdrawn
  • ||||||||||  zonisamide / Generic mfg.
    Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date:  Prevention of Noise-induced Hearing Loss (clinicaltrials.gov) -  Nov 6, 2017   
    P1/2,  N=0, Withdrawn, 
    N=120 --> 0 | Trial primary completion date: Jun 2014 --> Nov 2015 N=50 --> 0 | Initiation date: Jun 2017 --> Oct 2017 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2019 --> Nov 2017 | N=50 --> 0 | Initiation date: Jun 2017 --> Oct 2017 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2019 --> Nov 2017
  • ||||||||||  Trial completion, Phase classification:  The Effect of Pseudoephedrine on Rhinitis and Sleep (clinicaltrials.gov) -  Oct 18, 2017   
    P3,  N=34, Completed, 
    N=50 --> 0 | Initiation date: Jun 2017 --> Oct 2017 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2019 --> Nov 2017 | N=50 --> 0 | Initiation date: Jun 2017 --> Oct 2017 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2019 --> Nov 2017 Recruiting --> Completed | Phase classification: PN/A --> P3
  • ||||||||||  Trial primary completion date:  National Trends in Otitis Media in Children Under 5 Years of Age (clinicaltrials.gov) -  Oct 13, 2017   
    P=N/A,  N=1, Active, not recruiting, 
    Recruiting --> Completed | Phase classification: PN/A --> P3 Trial primary completion date: Aug 2017 --> Dec 2017
  • ||||||||||  Trial completion:  Evaluation of New Feedback Canceller for Carina (clinicaltrials.gov) -  Oct 9, 2017   
    P=N/A,  N=12, Completed, 
    Trial primary completion date: Aug 2017 --> Dec 2017 Recruiting --> Completed
  • ||||||||||  Phase classification:  MRI Laryngeal Imaging With a Surface Coil (clinicaltrials.gov) -  Oct 5, 2017   
    P,  N=3, Terminated, 
    Active, not recruiting --> Completed Phase classification: P=N/A --> P
  • ||||||||||  Keyzilen (esketamine) / Altamira Therap
    Enrollment closed:  TACTT3: AM-101 in the Treatment of Acute Tinnitus 3 (clinicaltrials.gov) -  Sep 26, 2017   
    P3,  N=750, Active, not recruiting, 
    Active, not recruiting --> Recruiting Recruiting --> Active, not recruiting
  • ||||||||||  Trial completion, Trial initiation date, Trial primary completion date:  Evaluation of Frequency Lowering Technique (clinicaltrials.gov) -  Sep 25, 2017   
    P=N/A,  N=30, Completed, 
    Trial primary completion date: Aug 2017 --> Aug 2018 Recruiting --> Completed | Initiation date: May 2014 --> Dec 2014 | Trial primary completion date: Dec 2014 --> Mar 2015
  • ||||||||||  Strefen / Reckitt Benckiser
    Enrollment change:  A Study of Flurbiprofen 8.75 mg Lozenge in Patient With Pharyngitis (clinicaltrials.gov) -  Sep 21, 2017   
    P3,  N=204, Completed, 
    Recruiting --> Completed | Initiation date: May 2014 --> Dec 2014 | Trial primary completion date: Dec 2014 --> Mar 2015 N=300 --> 204
  • ||||||||||  Veramyst (fluticasone furoate nasal spray) / GSK
    Enrollment change, Trial termination, Trial primary completion date:  Compare the Effects of Fluticasone Furoate Nasal Spray vs Placebo in Patients With Nasal Polypoid Disease (clinicaltrials.gov) -  Sep 13, 2017   
    P4,  N=7, Terminated, 
    Recruiting --> Completed | N=10 --> 5 N=30 --> 7 | Not yet recruiting --> Terminated | Trial primary completion date: Nov 2010 --> Jul 2010; Terminated based on mutual agreement between PI and sponsor (Glaxo Smith Kline)
  • ||||||||||  Trial completion, Enrollment change:  The Baltimore HEARS Pilot Study (clinicaltrials.gov) -  Sep 6, 2017   
    P=N/A,  N=15, Completed, 
    Recruiting --> Completed Active, not recruiting --> Completed | N=100 --> 15
  • ||||||||||  QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
    Trial completion, Enrollment change, Trial initiation date:  A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps (clinicaltrials.gov) -  Aug 28, 2017   
    P2,  N=30, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | N=60 --> 30 | Initiation date: Mar 2008 --> Nov 2006
  • ||||||||||  Enrollment change, Trial initiation date, Trial primary completion date:  Nasal Provocation Testing in Occupational Rhinitis (clinicaltrials.gov) -  Aug 16, 2017   
    P=N/A,  N=17, Completed, 
    N=40 --> 29 N=30 --> 17 | Initiation date: Aug 2011 --> Nov 2010 | Trial primary completion date: Sep 2012 --> Sep 2011